BLRX · NASDAQ
BioLineRx (BLRX) Stock Price & Fundamentals
BioLineRx (BLRX) closed at $576.28 on Oct 9, 2026, down 1.10% from the previous close of $582.71.
Share price, past year
1Y +10.12%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $576.28 |
| Sep 30, 2026 | $599.02 |
| Aug 31, 2026 | $564.46 |
| Jul 31, 2026 | $577.09 |
| Jun 30, 2026 | $535.47 |
| May 29, 2026 | $545.94 |
| Apr 30, 2026 | $539.90 |
| Mar 31, 2026 | $533.92 |
| Feb 27, 2026 | $518.98 |
| Jan 30, 2026 | $534.08 |
| Dec 31, 2025 | $527.99 |
| Nov 28, 2025 | $524.78 |
| Oct 31, 2025 | $494.35 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 2.6B
- Dividend yield
- —
- 52-week range
- $488.07 – $613.32
Market cap, P/E and dividend yield aren't shown for BioLineRx yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US.
Financials
BioLineRx reported revenue of $1.18M for fiscal 2025, down 95.92% from fiscal 2024.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.18M | −95.9% | — | — | $0.00 | −$8.10M |
| FY2024ended Dec 31, 2024 | $28.94M | +502.9% | — | — | −$0.01 | −$43.93M |
| FY2023ended Dec 31, 2023 | $4.80M | — | — | — | −$0.06 | −$22.72M |
| FY2022ended Dec 31, 2022 | $0.00 | — | — | — | −$0.03 | −$26.37M |
| FY2021ended Dec 31, 2021 | $0.00 | — | — | — | −$0.04 | −$23.67M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2025ended Jun 30, 2025 | $304.00K | — | $0.00 |
| Q2 FY2024ended Jun 30, 2024 | $5.39M | — | $0.00 |
| Q2 FY2023ended Jun 30, 2023 | $0.00 | — | −$0.02 |
Company profile
- Name
- BioLineRx Ltd.
- Ticker
- BLRX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 2 Hamaayan Street, Modi-In Technology Park, Modi-In, ISRAEL
- Incorporated in
- L3
- Fiscal year ends
- December
- SEC CIK
- 0001498403
Recent SEC filings
- Mar 27, 2026
- Mar 23, 2026
- Mar 31, 2025
- Mar 26, 2024
- Mar 26, 2024
- Mar 22, 2023
- Sep 9, 2022
- Mar 16, 2022
Frequently asked questions
What is BioLineRx's stock price?
BioLineRx (BLRX) closed at $576.28 on Oct 9, 2026, down 1.10% from the previous close of $582.71.
How much revenue does BioLineRx make?
BioLineRx reported revenue of $1.18M for fiscal 2025, down 95.92% from fiscal 2024.
Sources and methodology
Fundamentals come from BioLineRx Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures